β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS 6974-32-9 Assay ≥99.0% (HPLC) Clofarabine Intermediate High Cleanity Featured Image

β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS 6974-32-9 Assay ≥99.0% (HPLC) Clofarabine Intermediate High Purity

Nkọwa dị mkpirikpi:

Aha: β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate

Ọkụ: 6974-32-9

Ọdịdị: White ma ọ bụ Gbanyụọ-White Crystalline ntụ ntụ

Nyocha: ≥99.0% (HPLC)

Ihe dị n'etiti Clofarabine (CAS: 123318-82-1) na ọgwụgwọ ụmụaka nwere nnukwu ọrịa leukemia Lymphoblastic (ALL)

Inquiry: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Ihe ndị metụtara Clofarabine na-eweta azụmaahịa:
Clofarabine CAS: 123318-82-1
2-Deoxy-2-fluoro-1,3,5-tri-O-benzoyl-α-D-arabinofuranose CAS: 97614-43-2
β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate CAS: 6974-32-9
1,3,5-Tri-O-benzoyl-D-Ribofuranose CAS: 22224-41-5
2,6-Dichloropurine CAS: 5451-40-1

Njirimara kemịkalụ:

Aha Chemical	β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate
Ụdị okwu	1-O-Acetyl-2,3,5-tri-O-benzoyl-β-D-Ribofuranose
Nọmba CAS	6974-32-9
Nọmba CAT	RF-PI222
Ọnọdụ Ahịa	N'ọkwa, Mpụta Ihe ruru Tọn
Usoro ihe omimi	C28H24O9
Ibu molekụla	504.49
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	Ntụ ntụ kristal na-acha ọcha ma ọ bụ gbanyụọ
Usoro nyocha / nyocha	≥99.0% (HPLC)
Ebe Na-agbaze	126.0 ~ 133.0 ℃
Ọnwụ na ihicha	≤0.50%
Ihe fọdụrụ na mgbanye	≤0.50%
Mgbakọta adịghị ọcha	≤1.00%
Ọla dị arọ	≤20ppm
Nlele ọkọlọtọ	Standardkpụrụ ụlọ ọrụ
Ojiji	Ndị na-ahụ maka ọgwụ nke Clofarabine CAS: 123318-82-1

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe pụọ na ọkụ, mmiri mmiri na ọrịa nje.

Uru:

Ajụjụ:

Ngwa:

β-D-Ribofuranose 1-Acetate 2,3,5-Tribenzoate (CAS 6974-32-9) bụ etiti nke (Clofarabine CAS: 123318-82-1).Clofarabine (CAS: 123318-82-1) bụ akwụkwọ akụkọ purine nucleoside anticancer ọgwụ bụ nke mbụ ụlọ ọrụ Top10 biopharmaceutical nke United States-Genzyme Corporation mepụtara nke ọma na aha azụmaahịa bụ "Clofarabine".Na Disemba 28, 2004 US Food and Drug Administration (FDA) ji ọsọ ọsọ maka nkwado nke clofarabine maka ngwa ụmụaka nwere ọrịa leukemia refractory ma ọ bụ nlọghachi azụ nnukwu lymphocytic (ALL);ọ nwere mmetụta dị mma na ọgwụgwọ ọrịa leukemia na-enwe ndidi nke ọma na enweghị mmeghachi omume ọjọọ na-enweghị atụ.Enwere ike inye ya site na intravenously ma ọ bụ were ọnụ.Ọgwụ a bụ ngwaahịa izizi akwadoro maka inyefe maka ọgwụgwọ ọrịa leukemia ụmụaka n'ime ihe karịrị afọ iri.